Valuation: Luye Pharma Group Ltd.

Capitalization 1.03TCr 1.15TCr 148.05Cr 126.03Cr 116.9Cr 109.78Cr 204.08Cr 14TCr 216.56Cr 1.33TCr 529.06Cr 6.42TCr 555.18Cr 543.78Cr 23TCr P/E ratio 2025 *
16.4x
P/E ratio 2026 * 12.7x
Enterprise value 1.28TCr 1.43TCr 183.95Cr 156.58Cr 145.24Cr 136.4Cr 253.56Cr 17TCr 269.06Cr 1.66TCr 657.32Cr 7.98TCr 689.78Cr 675.61Cr 29TCr EV / Sales 2025 *
1.95x
EV / Sales 2026 * 1.7x
Free-Float
51.84%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.35%
1 week-3.99%
Current month+5.47%
1 month+0.35%
3 months-10.80%
6 months-22.31%
Current year+5.47%
More quotes
1 week 2.83
Extreme 2.83
2.98
1 month 2.7
Extreme 2.7
3.06
Current year 2.73
Extreme 2.73
3.06
1 year 1.67
Extreme 1.67
4.49
3 years 1.67
Extreme 1.67
4.49
5 years 1.67
Extreme 1.67
7
10 years 1.67
Extreme 1.67
9.86
More quotes
Manager TitleAgeSince
Chief Executive Officer 61 02/07/2003
Director of Finance/CFO 62 01/03/2012
President 60 30/03/2015
Director TitleAgeSince
Director/Board Member 67 01/07/2003
Director/Board Member 60 01/07/2003
Chairman 61 02/07/2003
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.35%-3.99%+38.28%-21.89% 147.54Cr
+0.82%+1.31%+46.48%+214.21% 97TCr
+0.22%-0.03%+47.48%+29.48% 53TCr
+0.91%-1.70%+26.36%+45.81% 38TCr
+0.93%+1.10%+28.76%+18.21% 37TCr
+1.66%-5.48%+22.69%+21.07% 28TCr
+0.66%-0.83%+28.80%+36.25% 28TCr
-1.74%-1.65%+13.45%-0.69% 28TCr
+6.11%+4.88%-30.84%-17.87% 26TCr
+1.01%+5.50%+26.29%+31.85% 19TCr
Average +1.22%-1.16%+24.77%+35.64% 35.21TCr
Weighted average by Cap. +0.97%-0.68%+29.95%+74.84%
See all sector performances

Financials

2025 *2026 *
Net sales 658.44Cr 736.2Cr 94Cr 80Cr 75Cr 70Cr 130.17Cr 8.64TCr 138.13Cr 851.13Cr 337.45Cr 4.1TCr 354.11Cr 346.84Cr 15TCr 732.92Cr 819.48Cr 105.11Cr 89Cr 83Cr 78Cr 144.89Cr 9.62TCr 153.75Cr 947.41Cr 375.62Cr 4.56TCr 394.17Cr 386.07Cr 17TCr
Net income 62Cr 69Cr 8.86Cr 7.54Cr 7Cr 6.57Cr 12Cr 811.12Cr 13Cr 80Cr 32Cr 384.48Cr 33Cr 33Cr 1.4TCr 78Cr 88Cr 11Cr 9.57Cr 8.88Cr 8.34Cr 15Cr 1.03TCr 16Cr 101.33Cr 40Cr 487.79Cr 42Cr 41Cr 1.78TCr
Net Debt 250.27Cr 279.82Cr 36Cr 31Cr 28Cr 27Cr 49Cr 3.29TCr 53Cr 323.51Cr 128.26Cr 1.56TCr 134.59Cr 131.83Cr 5.68TCr 215.03Cr 240.43Cr 31Cr 26Cr 24Cr 23Cr 43Cr 2.82TCr 45Cr 277.96Cr 110.2Cr 1.34TCr 115.65Cr 113.27Cr 4.88TCr
More financial data * Estimated data
Logo Luye Pharma Group Ltd.
Luye Pharma Group Ltd is a company mainly engaged in developing, producing, marketing and selling pharmaceutical products. The Company operates four segments, including Oncology Drugs segment, Cardiovascular System Drugs segment, Alimentary Tract and Metabolism Drugs segment, and Central Nervous System Drugs segment. The Oncology Drugs segment provides Lipusu, Boyounuo, Baituowei, CMNa and Mimeixin and other drugs. The Cardiovascular System Drugs segment provides Xuezhikang, Oukai and Maitongna and other drugs. The Alimentary Tract and Metabolism Drugs segment provides Bei Xi and other drugs. The Central Nervous System Drugs segment provides Seroquel, Ruoxinlin, Rykindo, Meibirui and Jinyouping and other drugs.
Employees
5,115
More about the company
Date Price Change Volume
22/26/22 2.890 $ +0.35% 79,79,544
21/26/21 2.880 $ +0.70% 82,99,900
20/26/20 2.860 $ -0.69% 83,36,000
19/26/19 2.880 $ -2.04% 1,37,35,500
16/26/16 2.940 $ -1.01% 68,30,800

Delayed Quote Hong Kong S.E., January 22, 2026 at 01:38 pm IST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
2.584CNY
Average target price
3.227CNY
Spread / Average Target
+24.88%
Consensus

Quarterly revenue - Rate of surprise